Company intelligence / Profile preview

RPW Technology

Maryknoll, New York, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

RPW Technology is a private U.S. healthtech and consumer neurotechnology company that develops and markets LIFTiD, a wearable transcranial direct current stimulation (tDCS) device. The company positions LIFTiD as a recreational neurostimulation product for healthy adults rather than as a therapeutic medical device. Its product is intended to support attention, focus, alertness, productivity, and performance through mild electrical stimulation delivered via forehead electrodes. RPW Technology appears to operate as a single-product commercial company rather than a traditional drug-development biotech, with sales conducted through its GetLiftid website. The company is based in New York and remains active as of 2025-2026.

Modalities: DeviceNon-pharmacological therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on RPW Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPW Technology.

Explore the full profile